Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P266: First step towards validation of the Quality of Working Life Questionnaire (QWLQ) in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

S. van Gennep1*, A.G. de Boer2, K.G. Gecse1, C.I. Ponsioen1, J.K. Sluiter2, G.R. D'Haens1, M. Löwenberg1

1Academic Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Academic Medical Center, Coronel Institute of Occupational Health, Amsterdam, The Netherlands

P267: Long-term outcome of anti-TNF therapy in children with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

J.H. Park1*, Y.J. Lee1,2, S.W. Mun1

1Pusan National University, Pediatrics, Yansan, South Korea, 2Pusan National University Yangsan Hospital, Pediatrics, Yangsan, South Korea

P268: Ocular manifestations in a tertiary IBD centre: Better to keep an eye onECCO '18 Vienna
Year: 2018
Authors:

G. Rizzatti1*, S. Gerardi1, C. Manganelli2, V. Petito1, C. Graziani1, G. Holleran1, L.R. Lopetuso1, E. Schiavoni1, D. Napolitano1, M. Pizzoferrato3, L. Laterza1, G. Ianiro1, A. Caporossi2, A. Papa4, A. Armuzzi4, A. Gasbarrini1, F. Scaldaferri1

1A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, Gastroenterological Area, Gastroenterological and Endocrino-Metabolical Sciences Department, Rome, Italy, 2A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, Head and Neck Department-Ophthalmology Division, Rome, Italy, 3A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, Hospital Nutrition Team, Rome, Italy, 4A. Gemelli University Policlinic Foundation - Catholic University of Sacred Heart, IBD Unit, Presidio Columbus, Rome, Italy

P269: A new dedicated capsule for diagnosis and monitoring of Crohn’s disease. First patient seriesECCO '18 Vienna
Year: 2018
Authors:

C. Calabrese1*, A. Calafiore1, P. Gionchetti1, G.E. Tontini2, F. Rizzello1, M. Vecchi3, M. Campieri1

1University of Bologna, Dept of Clinical and Surgical Sciences - IBD Unit, Bologna, Italy, 2IRCCS Policlinico San Donato, Milan, Italy, 3University of Milan, Milan, Italy

P270: Bile acid malabsorption incidence and diagnosis in clinical practiceECCO '18 Vienna
Year: 2018
Authors:

B. Gros1*, L. Mena2,3, J.M. Benítez1,3, E. Carmona2, S. Marín1,3, F. Maza2, R. Medina3, V. García-Sánchez1,3, E. Iglesias-Flores1,3

1Reina Sofia University Hospital, Gastroenterology, Córdoba, Spain, 2Reina Sofia University Hospital, Nuclear Medicine, Córdoba, Spain, 3Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain

P271: Predictive factors of a clinical severe course of Crohn’s disease: A monocentric studyECCO '18 Vienna
Year: 2018
Authors:

K. Agar*, L. Hamzaoui, S. Jardak, M. Medhioub, A. Khsiba, M.M. Azzouz

Med Taher Maamouri Hospital, GastroEnterology department, Nabeul, Tunisia

P272: Predictors of health-related quality of life in patients with newly diagnosed moderate to severe ulcerative colitis: Results from the MOSAIC cohort in KoreaECCO '18 Vienna
Year: 2018
Authors:

Y.M. Park1*, C.K. Lee1, S.N. Hong2, J.P. Im3, B.D. Ye4, J.M. Cha1, J.M. Cha1, S.-A. Jung5, K.-M. Lee6, D.I. Park7, Y.T. Jeen8, Y.S. Park9, J.H. Cheon10, H.-S. Kim11, Y. Kim11, H.J. Kim1

1Kyung Hee University, School of Medicine, Seoul, South Korea, 2Sungkyunkwan University, School of Medicine, Seoul, South Korea, 3Seoul National University, College of Medicine, Seoul, South Korea, 4University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, 5Ewha Womans University, School of Medicine, Seoul, South Korea, 6St. Vincent's Hospital, The Catholic University, Seoul, South Korea, 7Kangbuk Samsung Hospital Sungkyunkwan University, Department of Internal Medicine, Seoul, South Korea, 8Korea University, College of Medicine, Seoul, South Korea, 9Eulji University, College of Medicine, Seoul, South Korea, 10Yonsei University, College of Medicine, Seoul, South Korea, 11Janssen Korea, Medical affairs, Seoul, South Korea

P273: Efficacy and safety of upadacitinib maintenance treatment for moderate to severe Crohn’s disease: Results from the CELEST studyECCO '18 Vienna
Year: 2018
Authors:

J. Panes1*, W.J. Sandborn2, E.V. Loftus Jr.3, G. Van Assche4, S. Ghosh5, Q. Zhou6, S. Goteti6, J.V. Enejosa6, A.L. Pangan6, A.P. Lacerda6

1Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain, 2University of California San Diego, La Jolla, USA, 3Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, USA, 4University Hospitals Leuven, Leuven, Belgium, 5University of Birmingham, Birmingham, UK, 6AbbVie Inc., North Chicago, USA

P274: Factors driving treatment escalation in Crohn’s disease in the CALM trialECCO '18 Vienna
Year: 2018
Authors:

W. Reinisch1*, R. Panaccione2, P. Bossuyt3, F. Baert4, A. Armuzzi5, X. Hebuterne6,7, S. Danese8, W.J. Sandborn9, S. Schreiber10, G. D'Haens11, S. Berg12, Q. Zhou13, J. Petersson13, E. Neimark13, A.M. Robinson13, J.-F. Colombel14

1Medical University of Vienna, Vienna, Austria, 2University of Calgary, Calgary, Canada, 3Imelda General Hospital, Bonheiden, Belgium, 4AZ Delta Roeselare-Menen, Menen, Belgium, 5Presidio Columbus, Fondazione Policlinico Gemelli Università Cattolica, Rome, Italy, 6Service de Gastroentérologie et Nutrition Clinique, Nice, France, 7Université de Nice-Sophia-Antipolis, Nice, France, 8Istituto Clinico Humanitas, Milan, Italy, 9University of California San Diego, La Jolla, USA, 10University Hospital Schleswig-Holstein, Kiel, Germany, 11Academic Medical Center, Amsterdam, The Netherlands, 12AbbVie AB, Solna, Sweden, 13AbbVie Inc., North Chicago, USA, 14Icahn School of Medicine at Mount Sinai, New York, USA

P275: Clinical characteristics, associated malignancies and management of primary sclerosing colangitis in inflammatory bowel disease patients: A Spanish nationwide study based on the ENEIDA registryECCO '18 Vienna
Year: 2018
Authors:

I. Guerra1*, L. Bujanda2,3, J. Castro4, O. Merino5, J. Tosca6, B. Camps7, A. Gutiérrez8, J. Gordillo9, L. de Castro10, M. Iborra3,11, A.Y. Carbajo12, C. Taxonera13, I. Rodriguez - Lago14, F. Mesonero15, R. de Francisco16, G.J. Gómez-Gómez17, M. Chaparro3,18, C.A. Tardillo19, M. Rivero20, A. Algaba1, E. Martín-Arranz21, F. Cañete3,22, R. Vicente23, B. Sicilia24, B. Antolín25, V. Prieto26, L. Márquez27, J.M. Benítez28, P. Camo29, M. Piqueras30, C.J. Gargallo31, E. Hinojosa32, J.M. Huguet33, J.L. Pérez Calle34, M. Van Domselaar35, C. Rodriguez36, X. Calvet3,37, M.C. Muñoz38, M.F. García-Sepulcre39, F. Bermejo1, J.M. Bañales40, J.P. Gisbert3,18

1Hospital Universitario de Fuenlabrada, Department of Gastroenterology, Fuenlabrada, Spain, 2Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco UPV/EHU, Department of Gatroenterology, Donostia-San Sebastian, Spain, 3Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain, Spain, 4Hospital Clinic de Barcelona, Department of Gastroenterology, Barcelona, Spain, 5Hospital Universitario de Cruces, Department of Gastroenterology, Baracaldo, Vizcaya, Spain, 6Hospital Universitario Clínico de Valencia, Department of Medicine, University of Valencia, Valencia, Spain, 7Hospital Universitari de Bellvitge-IDIBELL, Department of Gastroenterology, Barcelona, Spain, 8Hospital General Universitario de Alicante, Department of Gastroenterology, Alicante, Spain, 9Hospital de la Santa Creu i Sant Pau, Department of Gastroenterology, Barcelona, Spain, 10Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica. Estructura Organizativa de Xestión Integrada de Vigo, Department of Gastroenterology, Vigo, Spain, 11Hospital Universitari i Politecnic La Fe, Department of Gastroenterology, Valencia, Spain, 12Hospital Universitario Rio Hortega, Department of Gastroenterology, Valladolid, Spain, 13Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos (IdISSC), Department of Gastroenterology, Madrid, Spain, 14Hospital de Galdakao, Department of Gastroenterology, Galdakao, Vizcaya, Spain, 15Hospital Universitario Ramón y Cajal, Department of Gastroenterology, Madrid, Spain, 16Hospital Universitario Central De Asturias, Department of Gastroenterology, Oviedo, Spain, 17Hospital 12 de Octubre, Department of Gastroenterology, Madrid, Spain, 18Hospital Universitario de La Princesa, Gastroenterology Unit, IIS-IP, Madrid, Spain, 19Hospital Universitario Nuestra Señora Candelaria, Department of Gastroenterology, Santa Cruz De Tenerife, Spain, 20Hospital Universitario Marques de Valdecilla, Department of Gastroenterology, Unit EII, Santander, Spain, 21Hospital Universitario La Paz, Department of Gastroenterology, Madrid, Spain, 22Hospital Universitari Germans Trias I Pujol, Department of Gastroenterology, Badalona, Spain, 23Hospital Universitario Miguel Servet, Department of Gastroenterology, Zaragoza, Spain, 24Hospital Universitario de Burgos, Department of Gastroenterology, Burgos, Spain, 25Hospital Clínico Universitario de Valladolid, Department of Gastroenterology, Valladolid, Spain, 26Hospital Universitario de Salamanca, Department of Gastroenterology, Salamanca, Spain, 27Parc de Salut Mar, Department of Gastroenterology, Barcelona, Spain, 28Hospital Universitario Reina Sofia, Department of Gastroenterology, Córdoba, Spain, 29Hospital General San Jorge, Department of Hepatology and Gastroenterology, Huesca, Spain, 30Consorci Sanitari Terrassa, Terrassa, Spain, 31Hospital Clínico Universitario "Lozano Blesa" and Aragón Health Research Institute (IIS Aragón), Department of Gastroenterology, Zaragoza, Spain, 32Hospital de Manises, Department of Gastroenterology, Valencia, Spain, 33Hospital General Universitario de Valencia, Department of Gastroenterology, Valencia, Spain, 34Hospital Universitario Fundación Alcorcón, Department of Gastroenterology, Madrid, Spain, 35Hospital Universitario de Torrejón, Department of Gastroenterology, Torrejón De Ardoz, Spain, 36Complejo hospitalario de Navarra, Department of Gastroenterology and Hepatology, Pamplona, Spain, 37Corporació Sanitària Universitària Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Spain, 38Hospital Universitario de Basurto, Department of Gastroenterology, Bilbao, Spain, 39Hospital de Elche, Department of Gastroenterology, Alicante, Spain, 40Head, Liver Diseases Group Biodonostia Research Institute-Donostia University Hospital- Assistant Professor of Medicine/Sciences University of Navarra, USA., Donostia, Spain

P276: Risk matrix model for prediction of one-year surgery in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

N. Imperatore*, A. Rispo, A. Testa, L. Bucci, G. Luglio, G.D. De Palma, M. Rea, O.M. Nardone, N. Caporaso, F. Castiglione

School of Medicine Federico II of Naples, Department of Clinical Medicine and Surgery, Naples, Italy

P277: A new pan enteric capsule for suspected or established IBD: A feasibility study assessing the system functionality to visualise and assess the small and large bowelsECCO '18 Vienna
Year: 2018
Authors:

R. Eliakim1*, C. Spada2, I. Fernandez-Urien Sainz3, H. Yanai4, A. Lahat1, Y. Ron4, S. Pecere2, G. Costamagna2, A. Schwartz5, I. Eyal6, A. Lapidus6, S. Adler5

1Sheba Medical Center, Institute of Gastroenterology, Ramat Gan, Israel, 2Policlinico Universitario “A Gemelli”, UO di Endoscopia Digestiva Chirurgica, Rome, Italy, 3Complejo Hospitalario de Navarra, Servicio de Digestivo, Pamplona, Spain, 4Sourasky Medical Center, Gastroenterology, Tel-Aviv, Israel, 5Shaare Tzedek Medical Center, Gastroenterology, Jerusalem, Israel, 6Medtronic Inc., Yoqneam, Israel

P278: Risk factors analysis for progression of low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis according to the SCENIC terminologyECCO '18 Vienna
Year: 2018
Authors:

N. Hida1*, K. Watanabe2, T. Miyazaki1, Y. Yokoyama1, T. Takagawa2, K. Kamikozuru1, M. Kawai1, Y. Kita1, T. Sato1, S. Nakamura1

1Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Nishinomiya, Hyogo, Japan, 2Hyogo College of Medicine, Department of Intestinal Inflammation Research, Nishinomiya, Hyogo, Japan

P279: Vedolizumab is safe for use in pregnant patients with IBD; report of our preliminary dataECCO '18 Vienna
Year: 2018
Authors:

A. Bar-Gil Shitrit1*, B. Koslowsky2, Y. Milgrom2, A. Lahat3, E. Goldin2, S. Granovsky- Grisaru4

1Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel, 2Shaare Zedek Medical Center, Digestive diseases institute, Jerusalem, Israel, 3Sheba Medical Center, Gastroenterology, Ramat Gan, Israel, 4Shaare Zedek Medical Center, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Jerusalem, Israel

P280: Reducing the overprescribing of oral corticosteroids in IBD using a steroid assessment toolECCO '18 Vienna
Year: 2018
Authors:

G. Scott1*, N. Roads1, W. Lewis2

1East Kent Hospitals University NHS Foundation Trust, Gastroenterology, Canterbury, UK, 2Medway Maritime Hospital, Gastroenterology, Gillingham, UK

P281: Combined clinical and biological response (concomitant CRP and faecal calprotectin reductions) in induction and maintenance from the phase 3 ustekinumab Crohn’s disease studiesECCO '18 Vienna
Year: 2018
Authors:

J.-F. Colombel1*, C. Gasink2, A. Oortwijn3, R. van Kruchten3, S. Sloan2, V. Laliman4, P. Rutgeerts5, S. Ghosh6, W. Sandborn7, B. Feagan8, B. Sands1

1Icahn School of Medicine at Mount Sinai, New York, USA, 2Janssen Scientific Affairs, LLC., Horsham, USA, 3Janssen Biologics B.V, Leiden, The Netherlands, 4Amaris International Consultancy, Toronto, Canada, 5University Hospital, Gasthuisberg, Leuven, Belgium, 6University of Birmingham, Birmingham, UK, 7University of California San Diego, La Jolla, USA, 8University of Western Ontario, Robarts Research Institute, London, Canada

P282: Despite surveillance and increased use of biologics and immunosuppressives colorectal cancer detection in IBD patients remains unchanged over the past ten yearsECCO '18 Vienna
Year: 2018
Authors:

U.N. Shivaji1*, S.C.L. Smith1,2, R. Hejmadi3, T. Iqbal1, N. Bhala1, R. Cooney1, S. Ghosh1,2, M. Iacucci1,2

1University Hospital Birmingham, Department of Gastroenterology, Birmingham, UK, 2Institute of Translational Medicine, Birmingham, UK, 3University Hospital Birmingham, Histopathology, Birmingham, UK

P283: Predicting outcomes in paediatric Crohn’s disease: A systematic reviewECCO '18 Vienna
Year: 2018
Authors:

A. Ricciuto1*, M. Aardoom2, E. Orlanski-Meyer3, N. Carman4, D. Turner3, L. de Ridder2, A. Griffiths1

1Hospital for Sick Children, University of Toronto, Toronto, Canada, 2Erasmus Medical Center Children's Hospital, Department of Paediatric Gastroenterology, Rotterdam, The Netherlands, 3The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, Jerusalem, Israel, 4Children's Hospital of Eastern Ontario, Department of Gastroenterology, Hepatology and Nutrition, Ottawa, Canada

P284: Risk of colorectal neoplasia, colectomy and responsiveness to biologic therapy in patients with inflammatory bowel disease and concomitant primary sclerosing cholangitis: A systematic reviewECCO '18 Vienna
Year: 2018
Authors:

K. Wu, A. Thompson, N. Sheng Ding*

St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Australia

P285: Crohn’s disease overall severity is predictive of disabling disease: Disease severity index evaluationECCO '18 Vienna
Year: 2018
Authors:

J. Pereira Rodrigues*, M. Sousa, J.C. Silva, T. Freitas, A.P. Silva, A. Rodrigues, J. Carvalho

Centro Hospitalar Vila Nova de Gaia/Espinho, Gastroenterology, Vila Nova de Gaia, Portugal